查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945105

水溶性金奈米棒市场按产品类型、表面功能化、应用、最终用户和分销管道划分，全球预测（2026-2032年）

Water-soluble Gold Nanorods Market by Product Type, Surface Functionalization, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，水溶性金奈米棒市场价值将达到 5,137 万美元，到 2026 年将成长至 5,997 万美元，到 2032 年将达到 8,184 万美元，复合年增长率为 6.87%。

关键市场统计数据
基准年 2025 5137万美元
预计年份：2026年 5997万美元
预测年份 2032 8184万美元
复合年增长率 (%) 6.87%

本书权威地介绍了水溶性金奈米棒的科学原理、稳定性以及决定其在生物医学和工业应用中实用化因素。

水溶性金奈米棒融合了奈米技术、表面化学和生物医学工程，在成像、治疗、感测和催化等众多领域展现出日益重要的应用价值。这些异向性奈米颗粒不仅具有金的固有等离子体特性，其可调的长宽比和表面化学性质使其能够在水性生物和化学环境中实现可控的相互作用。其溶解性和胶体稳定性对于转化研究至关重要，因为它们与水溶液的相容性为与生理介质、製剂製程以及下游分析技术的兼容性奠定了基础。

合成扩充性、表面改质技术和合作商业化的进步如何改变水溶性金奈米棒的未来

随着合成扩充性、表面设计和监管的同步发展，水溶性金奈米棒的研究模式也不断演变。过去，研究重点主要集中在概念验证的光学性质和体外性能上，而现在，研究方向已明显转向稳健、可扩展的化学方法，以实现一致的长宽比和最小的批次间差异。这种转变的驱动力源于从探索性研究转向可重复性材料的需求，以支持临床前和早期临床计画。

评估2025年美国关税如何影响奈米材料研发领域的供应链韧性、采购和业务永续营运

美国2025年关税的实施和调整为从事水溶性金奈米棒研究的机构带来了新的供应链和采购的考量。依赖进口前驱物、特种界面活性剂或契约製造服务的公司被迫重新评估其短期筹资策略和物流，以维持研发和生产的连续性。这些变化促使许多相关人员重新考虑供应商多元化、库存管理和本地采购方案，以确保实验进度和生产计画的顺利进行。

基于详细细分市场的洞察揭示了应用领域、终端用户需求、产品形式、通路和表面化学性质如何决定研发和商业化重点。

细分领域揭示了技术和商业性优先事项的交汇点，以及研发资源能发挥最大作用的领域。应用主导的细分则揭示了生物成像、催化作用、药物传递、动态疗法、光热治疗和感测等领域的广泛研究活动。在生物成像领域，研究分为电脑断层扫描和磁振造影，其中造影机制和功能涂层会影响生物分布和检测灵敏度。药物递送应用分为化疗和基因递送途径，每种途径对有效载荷相容性、释放动力学和安全性评估的要求各不相同。光热治疗研究进一步分为体外和体内两种环境，其中热剂量控制和标靶化策略对于潜在的临床应用日益重要。感测研发分为电化学感测和光学感测，反映了不同的读出方法、表面化学性质和整合挑战。

影响采购、监管和临床路径的区域趋势和策略生态系统（美洲、欧洲、中东和非洲、亚太地区）

区域趋势为水溶性金奈米棒的开发和应用带来了不同的机会和挑战。在美洲，以临床应用为导向的生物医学研究实力雄厚，成熟的创业环境以及密集的临床研究中心网络，正推动着早期合作和临床试验的发展。该地区的生态系统支持学术研究机构与产业参与者之间的合作，重点关注临床效用研究和中试生产能力。欧洲、中东和非洲地区拥有多元化的环境，健全的法规结构、一体化的研究丛集以及对安全和环境管治的重视，促进了严谨的临床前评估和监管对话；同时，部分国家的新兴研究中心推动了本地化生产和专业化应用。亚太地区兼具大规模生产能力和对奈米医学及诊断平台快速成长的投资，有利于规模化生产和成本效益，并促进製造商与下游医疗设备和製药整合商之间的密切合作。

技术提供者之间的竞争行为和策略能力着重于规模化、表面功能化和完善的品质体系，以加速转化伙伴关係。

在水溶性金奈米棒领域，各公司透过可扩展的合成方法、先进的表面功能化技术和监管合规能力来脱颖而出。市场参与企业涵盖了专业的奈米材料製造商、学术创业公司以及提供配方开发、规模化生产和分析服务的合约研发生产机构 (CDMO)。许多机构致力于开发整合解决方案，将颗粒合成、偶联技术和严谨的表征流程相结合，以加速从实验室演示到实用化应用结构的转换。

为加强可重复性、监管应对力和策略伙伴关係，以加速转化研究进展，各组织应采取实际的优先行动

为了将技术可能性转化为可验证且可重复的成果，并满足研究、临床和商业相关人员的需求，行业领导者应重点推进以下倡议：首先，透过投资稳健且可扩展的合成和品管框架，降低下游开发风险，最大限度地减少长宽比变异性，并确保在生理条件下胶体稳定性。其次，优先考虑多功能表面策略，根据需要将隐形涂层与标靶分子和可裂解连接子结合，以提高特异性，同时保持良好的安全性。第三，制定供应商资质认证计划和区域采购计划，以降低贸易政策变更和供应中断带来的风险，并确保关键投入的持续供应。

本研究的基础研究采用以证据为基础的混合方法研究途径，结合同侪审查的技术文献、专利映射、专家访谈和供应链分析，以确保得出可靠的研究结果。

本分析所依据的研究采用混合方法，结合实验文献、专利概况、专家访谈和供应链图谱，全面展现此技术及其生态系。技术见解由同行评审的合成通讯协定、光学表征和功能化化学研究以及针对胶体稳定性和生物相容性的方法比较研究提供支持。专利分析识别出创新集中的领域，从而深入了解智慧财产权趋势和潜在的自由实施权。

合成技术、表面改质技术和合作实用化策略将共同决定水溶性金奈米棒的潜力能否转化为永续的现实世界应用。

水溶性金奈米棒兼具科学潜力与实用化挑战。其独特的光学性质和表面可调控性使其在成像、感测、标靶治疗等众多领域极具吸引力。然而，要实现更广泛的应用，关键在于可重复的合成方法、明确的表面化学性质以及严格的安全性评估。能够将自身能力（例如严谨的分析能力、法规专业知识和生产伙伴关係关係）与目标应用策略结合的相关人员，将更有利于推动原型产品迈向实用化目标。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 水溶性金奈米棒市场（依产品类型划分）

  • 长棒状分子（超过50奈米）
  • 短棒状分子（小于50奈米）

9. 水溶性金奈米棒市场（依表面功能化划分）

  • 抗体包被
  • 聚乙二醇化
  • 胜肽涂层

第十章 水溶性金奈米棒市场依应用领域划分

  • 生物影像
    • CT影像
    • 磁振造影
  • 催化作用
  • 药物输送
    • 化疗药物输送
    • 基因传递
  • 动态疗法
  • 光热治疗
  • 感测
    • 电化学感测
    • 光学感

第十一章 水溶性金奈米棒市场（依最终用户划分）

  • 学术机构
  • 诊断中心
  • 製药公司
  • 研究所

第十二章 水溶性金奈米棒市场（依通路划分）

  • 直销
  • 经销商
  • 线上管道

第十三章 水溶性金奈米棒市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 水溶性金奈米棒市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国水溶性金奈米棒市场概况

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国水溶性金奈米棒市场

第十七章：中国水溶性金奈米棒市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Agilent Technologies, Inc.
  • Bangs Laboratories, Inc.
  • BBI Solutions OEM Limited
  • CD Bioparticles
  • Creative Biolabs
  • Cytodiagnostics Inc.
  • Meliorum Technologies Inc.
  • Nano Labs
  • NanoComposix Inc.
  • Nanocs Inc.
  • NanoHybrids Inc.
  • Nanopartz Inc.
  • Nanoprobes, Inc.
  • Nanotherapeutics, Inc.
  • PlasmaChem GmbH
  • Sigma-Aldrich Corporation by Merck Group
  • Sona Nanotech
  • Strem Chemicals, Inc. by Ascensus Specialties LLC
  • TANAKA Holdings Co., Ltd.
Product Code: MRR-8D2A80511E82

The Water-soluble Gold Nanorods Market was valued at USD 51.37 million in 2025 and is projected to grow to USD 59.97 million in 2026, with a CAGR of 6.87%, reaching USD 81.84 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 51.37 million
Estimated Year [2026] USD 59.97 million
Forecast Year [2032] USD 81.84 million
CAGR (%) 6.87%

An authoritative primer on the science, stability, and translational enablers that define water-soluble gold nanorods for biomedical and industrial applications

Water-soluble gold nanorods represent a convergence of nanotechnology, surface chemistry, and biomedical engineering with growing relevance across imaging, therapy, sensing, and catalysis. These anisotropic nanoparticles combine the plasmonic properties inherent to gold with tunable aspect ratios and surface chemistries that enable controlled interactions in aqueous biological and chemical environments. Their solubility and colloidal stability are central to translational research, because aqueous compatibility underpins compatibility with physiological media, formulation workflows, and downstream analytical techniques.

As interest in precision medicine and advanced diagnostics intensifies, researchers and technology adopters are refining synthesis protocols to yield reproducible particle geometries and narrow dispersity. Concurrently, surface functionalization strategies-ranging from polyethylene glycol grafting to antibody and peptide conjugation-extend biological targeting, minimize non-specific adsorption, and modulate circulation times. In parallel, advances in characterization such as single-particle spectroscopy, cryo-electron microscopy, and high-resolution chromatographic separation are improving quality control and batch comparability.

Regulatory awareness and safety profiling remain essential for adoption beyond academic labs. Toxicology assays increasingly emphasize long-term clearance pathways, protein corona effects, and dose-dependent biodistribution. Taken together, these technical and translational considerations establish water-soluble gold nanorods as a versatile platform that bridges laboratory innovation with heightened expectations for manufacturability, reproducibility, and clinical relevance.

How converging advances in synthesis scalability, surface engineering, and collaborative commercialization are reshaping the trajectory of water-soluble gold nanorods

The landscape for water-soluble gold nanorods is shifting as synthesis scalability, surface engineering, and regulatory scrutiny evolve in tandem. Historically, emphasis rested on demonstrating proof-of-concept optical properties and in vitro performance, but there is now a clear shift toward robust, scalable chemistries that deliver consistent aspect ratios and minimized batch-to-batch variability. This evolution is driven by the need to move from exploratory studies to reproducible materials that can underpin preclinical and early clinical programs.

Simultaneously, surface functionalization has matured from simple stabilizing ligands to multifunctional coatings designed to achieve targeted delivery, stealth behavior, and triggered responses. For example, PEGylation remains a standard approach to reduce opsonization, while antibody and peptide coatings introduce specificity for cellular and molecular targets. As a result, the technology is transitioning from purely optical demonstrators to integrated therapeutic and diagnostic constructs that can be engineered for multimodal applications.

Finally, the commercialization pathway is increasingly influenced by cross-sector collaborations between academic spinouts, contract development organizations, and device and pharmaceutical developers. These partnerships accelerate validation in application contexts such as imaging, sensing, and photothermal interventions, while also creating clearer expectations for manufacturing controls, documentation, and regulatory alignment. The cumulative effect is a more disciplined ecosystem that prioritizes reproducibility, translational readiness, and strategic alliances to bridge laboratory advances with real-world use cases.

Assessing how recent U.S. tariff measures enacted in twenty twenty-five are reshaping supply chain resilience, sourcing, and operational continuity in nanomaterials development

The imposition and adjustment of tariffs by the United States in twenty twenty-five have introduced a new dimension of supply chain and sourcing considerations for organizations working with water-soluble gold nanorods. Companies that rely on imported precursors, specialized surfactants, or contract manufacturing services have had to evaluate near-term procurement strategies and logistics to preserve continuity of research and production. These shifts have prompted many stakeholders to re-examine supplier diversification, inventory management, and regional sourcing alternatives in order to maintain experimental timelines and production schedules.

In response, some research organizations and manufacturers prioritized local supplier qualification and expanded relationships with regional chemical producers to reduce exposure to cross-border tariff fluctuations. At the same time, laboratories and product developers adjusted procurement planning to account for longer lead times and potential cost variability for certain reagents and specialty substrates. The ripple effects also touched collaborative projects that involve international partners, necessitating clearer contractual terms around responsibilities for customs, duties, and materials transfer.

Looking forward, these trade policy dynamics reinforced the value of transparency in supplier capabilities and traceability in material provenance. Organizations that invest in validated domestic supply chains and robust quality assurance pathways can mitigate risk and strengthen operational resilience. Equally, entities that map their exposure to tariff-sensitive inputs and maintain adaptive sourcing strategies are better positioned to sustain development momentum amid trade policy volatility.

Detailed segmentation-driven insights revealing how application niches, end-user needs, product geometry, distribution pathways, and surface chemistries define R&D and commercialization priorities

Segment-level differentiation illuminates where technical and commercial priorities intersect and where development resources offer the greatest leverage for impact. Application-driven segmentation shows a broad distribution of activity across biological imaging, catalysis, drug delivery, photodynamic therapy, photothermal therapy, and sensing. Within biological imaging, research divides into computed tomography and magnetic resonance approaches where contrast mechanisms and functional coatings alter biodistribution and detection sensitivity. Drug delivery applications separate into chemotherapeutic delivery and gene delivery pathways, each demanding distinct payload compatibility, release kinetics, and safety assessments. Photothermal therapy work is further distinguished by in vitro versus in vivo contexts, with thermal dose control and targeting strategies becoming critical for translational candidacy. Sensing R&D bifurcates into electrochemical and optical sensing, reflecting differing readout modalities, surface chemistries, and integration challenges.

End-user segmentation underscores how adoption pathways vary across research and commercial settings. Academic institutes and research institutes typically drive fundamental innovation, method development, and early validation, whereas diagnostic centers and pharmaceutical companies focus on clinical utility, regulatory alignment, and integration into workflows. Product type segmentation highlights distinctions between long rods with greater than fifty nanometer dimensions and short rods below that threshold, which exhibit different optical resonances, cellular interactions, and clearance behaviors. Distribution channel segmentation shapes purchasing and support expectations through direct sales, distributors, and online channels, each with tradeoffs in technical support, batch traceability, and turnaround times. Surface functionalization segmentation - including antibody-coated, PEGylated, and peptide-coated variants - directs intended biological interactions, immunogenicity profiles, and targeting specificity, thereby influencing translational strategies at every stage.

Regional dynamics and strategic ecosystems across the Americas, Europe Middle East & Africa, and Asia Pacific that influence sourcing, regulation, and translational pathways

Regional dynamics create distinct opportunity sets and constraints for the development and adoption of water-soluble gold nanorods. In the Americas, strength in translational biomedical research, a mature venture landscape, and a dense network of clinical research sites drive early-stage collaborations and translational testing. This regional ecosystem supports partnerships between academic labs and industry players focused on clinical utility studies and pilot manufacturing capabilities. Europe, Middle East & Africa present a heterogeneous landscape where strong regulatory frameworks, consolidated research clusters, and an emphasis on safety and environmental governance encourage rigorous preclinical evaluation and dialogue with regulatory agencies; meanwhile, emerging research centers in certain countries are advancing localized manufacturing and specialized applications. Asia-Pacific combines high-volume manufacturing capabilities with rapidly growing investment in nanomedicine and diagnostic platforms, encouraging scale-up and cost-efficient production as well as close integration between manufacturers and downstream device or pharmaceutical integrators.

Supply chain composition and regulatory environments also differ across these regions, shaping decisions about where to qualify suppliers, establish contract development and manufacturing partnerships, and conduct pivotal preclinical work. For example, proximity to specialty chemical suppliers and instrument manufacturers can shorten development cycles in certain Asia-Pacific hubs, while established clinical trial networks in the Americas and parts of Europe support more rapid translational assessments. These regional distinctions inform strategic choices about pilot production, regulatory engagement, and partnership models that best align with organizational priorities and timelines.

Competitive behaviors and strategic capabilities among technology providers that emphasize scale-up, surface functionalization, and documented quality systems to accelerate translational partnerships

Companies operating in the water-soluble gold nanorod space are differentiating through capabilities in scalable synthesis, advanced surface functionalization, and regulatory alignment. Market participants range from specialized nanomaterials manufacturers and academic spinouts to contract development and manufacturing organizations that provide formulation, scale-up, and analytical services. Many organizations emphasize integrated solutions that combine particle synthesis with conjugation expertise and rigorous characterization workflows to shorten the path from laboratory proof to application-ready constructs.

Strategic behavior includes forming multidisciplinary alliances that bring together chemists, biologists, and engineers to address complex translational challenges such as in vivo stability, immunogenicity, and delivery efficiency. In addition, some providers are investing in standardized quality systems and documented production processes to improve reproducibility and to facilitate regulatory conversations. Contract research and manufacturing relationships are growing more common as end users seek partners that can support method transfer, scale-up, and lot release testing.

At the same time, intellectual property considerations influence collaboration structures. Patent landscapes around synthesis techniques, surface chemistries, and application-specific conjugates encourage licensing discussions and guarded technology transfer approaches. Companies with strong analytical platforms and validated safety data are better positioned to attract partnerships with diagnostic developers and therapeutic integrators, and firms that can demonstrate consistent manufacturing and documentation practices secure an advantage when negotiating development contracts and supply agreements.

Practical and prioritized actions for organizations to enhance reproducibility, regulatory readiness, and strategic partnerships that accelerate translational progress

Industry leaders should pursue a set of targeted actions to convert technical promise into demonstrable, reproducible outcomes that satisfy research, clinical, and commercial stakeholders. First, invest in robust, scalable synthesis and quality-control frameworks that minimize aspect ratio variability and ensure colloidal stability under physiological conditions, thereby reducing downstream development risk. Second, prioritize multifunctional surface strategies, combining stealth coatings with targeting moieties and cleavable linkers where appropriate, to enhance specificity while maintaining favorable safety profiles. Third, develop supplier qualification programs and regional sourcing plans to mitigate exposure to trade policy shifts and supply disruptions, ensuring continuity of critical inputs.

Fourth, integrate preclinical safety and pharmacokinetic studies early to validate clearance mechanisms, protein corona dynamics, and dose-dependent biodistribution, and align experimental design with regulatory expectations to expedite review conversations. Fifth, establish partnerships with contract development and manufacturing organizations that can demonstrate analytical rigor and method transfer experience, enabling smoother transitions from bench to pilot production. Sixth, create interdisciplinary teams that include regulatory, clinical, and commercial expertise to craft go-to-market strategies tailored to imaging, therapeutic, and sensing applications. By implementing these actions in parallel, organizations can reduce translational friction and better position their technologies for adoption across both research and clinical markets.

An evidence-based mixed-methods research approach combining peer-reviewed technical literature, patent mapping, expert interviews, and supply chain analysis to ensure robust insights

The research underpinning this analysis draws on a mixed-methods approach that triangulates experimental literature, patent landscapes, expert interviews, and supply chain mapping to provide a holistic view of the technology and its ecosystem. Technical insights were informed by peer-reviewed studies on synthesis protocols, optical characterization, and functionalization chemistries, as well as by method comparison studies that address colloidal stability and biocompatibility. Patent analysis identified areas of concentrated innovation, informing discussion on intellectual property dynamics and potential freedom-to-operate considerations.

Qualitative inputs came from structured interviews with academic investigators, R&D leaders in companies developing nanomaterials, and specialists in regulatory science and manufacturing scale-up. These conversations illuminated practical barriers to translation, such as analytical gaps, documentation needs, and partnership expectations. Finally, supply chain mapping and procurement interviews provided visibility into typical sourcing pathways, logistical constraints, and regional manufacturing capabilities. Throughout, careful attention was paid to corroborating claims across multiple sources and to contextualizing findings within current regulatory trends and best-practice approaches to nanomaterial characterization and safety assessment.

Synthesis, surface engineering, and collaborative translational strategies that collectively determine whether the promise of water-soluble gold nanorods converts into sustained real-world applications

Water-soluble gold nanorods sit at an intersection of scientific opportunity and pragmatic development challenges. Their unique optical and surface-tunable properties make them attractive for a range of applications from imaging and sensing to targeted therapy, yet the pathway to broader adoption requires attention to reproducible synthesis, well-defined surface chemistries, and rigorous safety characterization. Stakeholders who align internal capabilities-such as analytical rigor, regulatory expertise, and manufacturing partnerships-with targeted application strategies will be best positioned to advance prototypes toward translational milestones.

Moreover, the evolving trade and supply chain landscape underscores the importance of flexible sourcing strategies and regional qualification to preserve momentum in research and production. Collaboration across disciplines and sectors remains a powerful lever to resolve technical bottlenecks and to accelerate validation in clinically relevant contexts. In summary, the technology's promise is real, but realizing that promise at scale depends on disciplined engineering, strategic partnerships, and a proactive approach to regulatory and supply chain risks.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Water-soluble Gold Nanorods Market, by Product Type

  • 8.1. Long Rods (>50 Nm)
  • 8.2. Short Rods (<50 Nm)

9. Water-soluble Gold Nanorods Market, by Surface Functionalization

  • 9.1. Antibody Coated
  • 9.2. PEGylated
  • 9.3. Peptide Coated

10. Water-soluble Gold Nanorods Market, by Application

  • 10.1. Biological Imaging
    • 10.1.1. CT Imaging
    • 10.1.2. MRI Imaging
  • 10.2. Catalysis
  • 10.3. Drug Delivery
    • 10.3.1. Chemotherapeutic Delivery
    • 10.3.2. Gene Delivery
  • 10.4. Photodynamic Therapy
  • 10.5. Photothermal Therapy
  • 10.6. Sensing
    • 10.6.1. Electrochemical Sensing
    • 10.6.2. Optical Sensing

11. Water-soluble Gold Nanorods Market, by End User

  • 11.1. Academic Institutes
  • 11.2. Diagnostic Centers
  • 11.3. Pharmaceutical Companies
  • 11.4. Research Institutes

12. Water-soluble Gold Nanorods Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Online Channels

13. Water-soluble Gold Nanorods Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Water-soluble Gold Nanorods Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Water-soluble Gold Nanorods Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Water-soluble Gold Nanorods Market

17. China Water-soluble Gold Nanorods Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Agilent Technologies, Inc.
  • 18.6. Bangs Laboratories, Inc.
  • 18.7. BBI Solutions OEM Limited
  • 18.8. CD Bioparticles
  • 18.9. Creative Biolabs
  • 18.10. Cytodiagnostics Inc.
  • 18.11. Meliorum Technologies Inc.
  • 18.12. Nano Labs
  • 18.13. NanoComposix Inc.
  • 18.14. Nanocs Inc.
  • 18.15. NanoHybrids Inc.
  • 18.16. Nanopartz Inc.
  • 18.17. Nanoprobes, Inc.
  • 18.18. Nanotherapeutics, Inc.
  • 18.19. PlasmaChem GmbH
  • 18.20. Sigma-Aldrich Corporation by Merck Group
  • 18.21. Sona Nanotech
  • 18.22. Strem Chemicals, Inc. by Ascensus Specialties LLC
  • 18.23. TANAKA Holdings Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY LONG RODS (>50 NM), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY LONG RODS (>50 NM), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY LONG RODS (>50 NM), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SHORT RODS (<50 NM), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SHORT RODS (<50 NM), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SHORT RODS (<50 NM), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ANTIBODY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEGYLATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEGYLATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEGYLATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEPTIDE COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEPTIDE COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PEPTIDE COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CT IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CT IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CT IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY MRI IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY MRI IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY MRI IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CATALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CATALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CATALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CHEMOTHERAPEUTIC DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CHEMOTHERAPEUTIC DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY CHEMOTHERAPEUTIC DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GENE DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GENE DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GENE DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTODYNAMIC THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHOTOTHERMAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ELECTROCHEMICAL SENSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ELECTROCHEMICAL SENSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ELECTROCHEMICAL SENSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY OPTICAL SENSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY OPTICAL SENSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY OPTICAL SENSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 168. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 170. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 172. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GCC WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 195. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 197. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 198. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 199. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 204. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 206. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 208. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SURFACE FUNCTIONALIZATION, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY BIOLOGICAL IMAGING, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DRUG DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY SENSING, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA WATER-SOLUBLE GOLD NANORODS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)